CD44 and breast cancer: For example, Baccelli et al. reported that the presence of luminal breast cancer metastasis-initiating cells (MICs) with the characteristic EPCAM+CD44+CD47+MET+/− phenotype correlates with lower overall survival and increased number of metastatic sites5.